AIM
NVAX icon

Aigen Investment Management’s Novavax NVAX Stock Holding History

Aigen Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,369
Closed -$247K – 913
2021
Q4 		$247K Buy
+1,369
New +$235K 0.02% 861
2020
Q3 		– Sell
-5,213
Closed -$435K – 1031
2020
Q2 		$435K Buy
+5,213
New +$199K 0.06% 508

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aigen Investment Management's NVAX Position: Q1 2022 in Review

Aigen Investment Management sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,369 shares — an estimated $247K sold.

Aigen Investment Management first reported a position in NVAX in Q2 2020 and held it in 2 quarters. The position peaked at $435K in Q2 2020. 381 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Aigen Investment Management reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Aigen Investment Management sold 1,369 Novavax shares in Q1 2022, an estimated $247K.
  • Aigen Investment Management first reported a position in Novavax in Q2 2020 and held it in 2 quarters.
  • Aigen Investment Management's Novavax position peaked at $435K in Q2 2020.
  • 381 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Aigen Investment Management's 13F filing for Q1 2022, filed 5 May 2022.